The Cancer Center at NIT is a Basic Cancer Center comprising three integrated research programs involving more than two dozen laboratories at NIT. Most laboratories are located in three buildings of the Biology Department (Cancer Center, Biology building, Whitehead Institute) and share many common research facilities. Research programs focus on the underlying cell and molecular biology of cell behavior with particular emphasis on issues related to cancer; control of cell proliferation, cell cycle and cell survival, gene expression, cell adhesion and migration, tumor progression, angiogenesis and metastasis. There is a strong emphasis on the use of genetics and molecular genetics to discover genes controlling these processes and/or altered in cancer using human genomics and genetic studies in model organisms (mice, zebrafish, invertebrates and yeast). Three programs in Molecular Genetics & Immunology, Tumor Suppressors, Cell Cycle & Checkpoints, and Cell Biology, Development & Differentiation unite the center members; each is headed by a leader in the field. The major budget requests are to fund shared facilities (Biopolymers, Cell Sorter, Computing Glassware, Histology, Media Preparation, Microarray Technologies, Microscopy, Monoclonal Antibodies, Shared Research Resources, Transgenic Mouse Facility) and infrastructure that support and enhance the scientific research of the center and for developmental funds to foster new directions and initiatives in cancer research. No funds are requested for senior leadership or staff investigator salaries.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014051-30
Application #
6375566
Study Section
Subcommittee G - Education (NCI)
Program Officer
Shafik, Hasnaa
Project Start
1975-09-01
Project End
2005-04-30
Budget Start
2001-06-01
Budget End
2002-04-30
Support Year
30
Fiscal Year
2001
Total Cost
$1,670,013
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Internal Medicine/Medicine
Type
Schools of Arts and Sciences
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Wong, Madeline Y; Doan, Ngoc Duc; DiChiara, Andrew S et al. (2018) A High-Throughput Assay for Collagen Secretion Suggests an Unanticipated Role for Hsp90 in Collagen Production. Biochemistry 57:2814-2827
Danai, Laura V; Babic, Ana; Rosenthal, Michael H et al. (2018) Altered exocrine function can drive adipose wasting in early pancreatic cancer. Nature 558:600-604
Dubbury, Sara J; Boutz, Paul L; Sharp, Phillip A (2018) CDK12 regulates DNA repair genes by suppressing intronic polyadenylation. Nature 564:141-145
Crowell, Laura E; Lu, Amos E; Love, Kerry R et al. (2018) On-demand manufacturing of clinical-quality biopharmaceuticals. Nat Biotechnol :
Tokatlian, Talar; Kulp, Daniel W; Mutafyan, Andrew A et al. (2018) Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes. Sci Rep 8:16527
Berger, Gilles; Grauwet, Korneel; Zhang, Hong et al. (2018) Anticancer activity of osmium(VI) nitrido complexes in patient-derived glioblastoma initiating cells and in vivo mouse models. Cancer Lett 416:138-148
Lo, Justin H; Hao, Liangliang; Muzumdar, Mandar D et al. (2018) iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer. Mol Cancer Ther 17:2377-2388
Phillips, Angela M; Doud, Michael B; Gonzalez, Luna O et al. (2018) Enhanced ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin. Elife 7:
Johnson, Hannah; White, Forest M (2018) Quantitative Analysis of Tyrosine Kinase Signaling Across Differentially Embedded Human Glioblastoma Tumors. Methods Mol Biol 1711:149-164
Tentori, Augusto M; Nagarajan, Maxwell B; Kim, Jae Jung et al. (2018) Quantitative and multiplex microRNA assays from unprocessed cells in isolated nanoliter well arrays. Lab Chip 18:2410-2424

Showing the most recent 10 out of 904 publications